Citigroup’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-42,300
Closed -$261K – 7764
2018
Q3
$261K Buy
42,300
+13,300
+46% +$60.1K ﹤0.01% 4963
2018
Q2
$185K Buy
29,000
+19,800
+215% +$141K ﹤0.01% 5150
2018
Q1
$64K Sell
9,200
-7,000
-43% -$81.5K ﹤0.01% 5980
2017
Q4
$204K Sell
16,200
-6,300
-28% -$76.8K ﹤0.01% 5021
2017
Q3
$267K Buy
22,500
+6,400
+40% +$94.9K ﹤0.01% 4734
2017
Q2
$241K Buy
+16,100
New +$215K ﹤0.01% 4638

Other funds holding MDXG

Citigroup's MDXG Position: Q3 2026 in Review

Citigroup reduced its MiMedx Group (MDXG) stake by 72% in Q3 2026, selling an estimated $411K and leaving 36,749 shares worth $171K. The position accounts for ﹤0.01% of the portfolio, ranked #4277.

Citigroup first reported a position in MDXG in Q3 2013 and has held it in 45 quarters since. The position peaked at $7.36M in Q2 2015. 169 funds tracked by Wall St. Rank hold MDXG as of Q3 2026.

  • Citigroup held 36,749 shares of MiMedx Group worth $171K as of Q3 2026.
  • Citigroup sold 93,545 MiMedx Group shares in Q3 2026, an estimated $411K.
  • MiMedx Group made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #4277 holding.
  • Citigroup first reported a position in MiMedx Group in Q3 2013 and has held it in 45 quarters since.
  • Citigroup's MiMedx Group position peaked at $7.36M in Q2 2015.
  • 169 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.